Epigenomics at 360°in Liquid Biopsy: Approaches & Case Studies for Biomarker Discovery & Drug Development
- Hologic Diagenode empowers biomarker discovery and drug development through advanced epigenomic profiling and AI/ML-driven bioinformatics
- Our newly expanded portfolio extends beyond cfDNA methylation to encompass chromatin and circulating nucleosome quantification, as well as transcriptomics via comprehensive cfRNA profiling from liquid biopsy-derived material
- We will present real-world case studies illustrating how epigenomic approaches can be applied to treatment response monitoring, assessment of drug efficacy, and diagnostic applications